Registro nacional de pacientes con lupus eritematoso sistémico de la Sociedad Española de Reumatología: objetivos y metodología

Bertoli, 2007, Epidemiology of systemic lupus erythematosus, 1 2001 Carmona, 2001, The burden of musculoeskeletal diseases in the general population of Spain: Results from a nation-wide study, Ann Rheum Dis, 60, 1040, 10.1136/ard.60.11.1040 McElhone, 2006, A review of health related quality of life in systemic lupus erythematosus, Lupus, 15, 633, 10.1177/0961203306071710 Rúa-Figueroa, 2008, Factores asociados a la mortalidad del lupus eritematoso sistémico, Semin Fund Esp Reumatol, 09, 219, 10.1016/S1577-3566(08)75215-1 Bernatsky, 2006, Mortality in systemic lupus erythematosus, Arthritis Rheum, 54, 2550, 10.1002/art.21955 Panopalis, 2008, Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus, Arthritis Rheum, 59, 1788, 10.1002/art.24063 Smolen, 1999, Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains, J Rheumatol, 26, 504 Uribe, 2004, What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. Nurture) cohort? Where are we heading?, Autoimmun Rev, 3, 321, 10.1016/j.autrev.2003.11.005 Kremer, 2008, The role of drug and disease registries in rheumatic disease epidemiology, Curr Opin Rheumatol, 20, 123, 10.1097/BOR.0b013e3282f50eb1 Gliklich, 2007, Duke Evidence-based Practice Center. Registries for evaluating patient outcomes: A user's guide, AHRQ Pub, 1 Lu, 2010, Lupus registries: Evolution and challenges, Semin Arthritis Rheum, 39, 224, 10.1016/j.semarthrit.2008.08.009 Villa-Blanco, 2012, Utilizing registries in systemic lupus erythematosus clinical research, Expert Rev Clin Immunol, 8, 353, 10.1586/eci.12.20 Urowitz, 2005, Contributions of observational cohort studies in systemic lupus erythematosus: The University of Toronto lupus clinic experience, Rheum Dis Clin North Am, 31, 211, 10.1016/j.rdc.2005.01.008 Calvo-Alén, 2003, Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry, Lupus, 12, 377, 10.1191/0961203303lu372oa Calvo-Alén, 2005, Effect of ethnicity on disease activity in systemic lupus erythematosus, J Rheumatol, 32, 962 Pons-Estel, 2004, The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: Ethnic and disease heterogeneity among Hispanics, Medicine (Baltimore), 83, 1, 10.1097/01.md.0000104742.42401.e2 Alarcón, 2002, Baseline characteristics of a multiethnic lupus cohort: PROFILE, Lupus, 11, 95, 10.1191/9612332lu155oa Cooper, 2002, Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States, Lupus, 11, 161, 10.1191/0961203302lu161oa Petri, 2005, Lupus in Baltimore: Evidence-based ‘clinical pearls’ from the Hopkins Lupus Cohort, Lupus, 14, 970, 10.1191/0961203305lu2230xx Appel, 2009, Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis, J Am Soc Nephrol, 20, 1103, 10.1681/ASN.2008101028 Bertsias, 2008, EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics, Ann Rheum Dis, 67, 195, 10.1136/ard.2007.070367 Blanco, 1998, Survival analysis of 306 European Spanish patients with systemic lupus erythematosus, Lupus, 7, 159, 10.1191/096120398678919930 López-Longo, 2003, Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage, Lupus, 12, 813, 10.1191/0961203303lu470oa Cervera, 1993, Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus, Medicine (Baltimore), 72, 113, 10.1097/00005792-199303000-00005 Rúa-Figueroa, 2010, Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: A 2-year longitudinal study, Ann Rheum Dis, 69, 1136, 10.1136/ard.2008.104349 Pego-Reigosa, 2013, Efficacy and safety of non-biologic immunusuppresants in the treatment of non-renal systemic lupus erythematosus: A systematic review, Arthritis Care Res (Hoboken), 10.1002/acr.22035 Pego-Reigosa, 2008, Systemic lupus erythematosus: Pharmacological developments and recommendations for a therapeutic strategy, Expert Opin Investig Drugs, 17, 31, 10.1517/13543784.17.1.31 Swaak, 2001, Incomplete lupus erythematosus: Results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT), Rheumatology (Oxford), 40, 89, 10.1093/rheumatology/40.1.89 Tan, 1982, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 25, 1271, 10.1002/art.1780251101 Hochberg, 1997, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 40, 1725, 10.1002/art.1780400928 Hawker, 1993, A reliability study of SLEDAI: A disease activity index for systemic lupus erythematosus, J Rheumatol, 20, 657 Symmons, 1988, Development of a computerised index of clinical disease activity in systemic lupus erythematosus, Q J Med, 69, 927 Yee, 2006, Revised British Isles Lupus Assessment Group 2004 Index. A reliable tool for assessment of systemic lupus erythematosus activity, Arthritis Rheum, 54, 3300, 10.1002/art.22162 Gladman, 1996, The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus, Arthritis Rheum, 39, 363, 10.1002/art.1780390303 Petri, 2005, Combined oral contraceptives in women with systemic lupus erythematosus, N Engl J Med, 353, 2550, 10.1056/NEJMoa051135 Katz, 1993, A simple severity of disease index for systemic lupus erythematosus, Lupus, 2, 119, 10.1177/096120339300200210 Deyo, 1992, Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases, J Clin Epidemiol, 45, 613, 10.1016/0895-4356(92)90133-8 Miyakis, 2006, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost, 4, 295, 10.1111/j.1538-7836.2006.01753.x Alarcón-Segovia, 1989, Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients, J Rheumatol, 16, 328 World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. [consultado 6 Jul 2013]. Disponible en: http://www.wma.net/en/20activities/10ethics/10helsinki Convenio para la protección de los derechos humanos y la dignidad del ser humano con respecto a las aplicaciones de la biología y la medicina. Guía Internacional de la Bioética. [consultado 6 Jul 2013]. Disponible en: http://www.bioeticas.net/leg/001.htm Ley Orgánica 15/1999 de 13 de diciembre de Protección de Datos de Carácter Personal. Boletín Oficial del Estado 1999; núm. 298, p. 43088–99. Lim, 2009, Population-based lupus registries: advancing our epidemiologic understanding, Arthritis Rheum, 15, 1462, 10.1002/art.24835 Dixon, 2010, EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology, Ann Rheum Dis, 69, 1596, 10.1136/ard.2009.125526 Gómez de la Cámara, 1997, The loss of reliability in data extraction from clinical histories: The source of the flaws and the usefulness of training, Med Clin (Barc), 108, 377 Mayes, 1997, Connective tissue disease registries, Arthritis Rheum, 40, 1556, 10.1002/art.1780400903